HIV cascade of care in Greece: Useful insights from additional stages
- PMID: 30440000
- PMCID: PMC6237384
- DOI: 10.1371/journal.pone.0207355
HIV cascade of care in Greece: Useful insights from additional stages
Abstract
Background: Aiming to eliminate HIV infection, UNAIDS has set a global "90-90-90" target by 2020. We sought to construct a 6-stages HIV Cascade of Care (CoC) in Greece, overall and by risk group, to assess risk-group and stage-specific progress in achieving the UNAIDS target.
Patients and methods: Combining data from the HIV/AIDS surveillance system and a population-based HIV cohort study, the CoC included: i) number of people living with HIV (PLHIV) by end of 2013; ii) proportion of PLHIV ever diagnosed; iii) proportion of diagnosed linked-to-care iv) proportion of linked-to-care ever initiating antiretroviral therapy (ART); v) proportion of treated who retained-in-care vi) proportion of those retained-in-care who were virally suppressed (≤200 copies/mL) at their last visit (01/07/2012-31/12/2013).
Results: In 2013, 14147 PLHIV were in Greece. Overall, proportions of each stage in the cascade were: 78.4% diagnosed; 86% linked-to-care; 78.5% initiated ART; 86.4% retained-in-care, and 87.1% virally suppressed. Totally, 42.6% of all PLHIV were virally suppressed. The percentage diagnosed was lower among heterosexual men and women (heterosexuals) than in MSM (men who have sex with men) or PWID (people who inject drugs). Most MSM were linked to care (97.2% of diagnosed) while a substantial proportion of PWID were not (80.8% of diagnosed). Once treated, PWID remained in care in similar proportions to MSM. Unlike PWID, a high proportion of the retained in care MSM and heterosexuals achieved viral suppression.
Conclusions: At the end of 2013, we identified gaps in the HIV CoC in Greece, which differed across risk groups. Targeted interventions are critical in optimizing early diagnosis and timely linkage. A 6-stage CoC, stratified by risk group, can inform strategic public health planning in improving HIV treatment outcomes.
Conflict of interest statement
GT has received grants unrelated to this study from Gilead Sciences Europe, UCL, ECDC and EU and National fund. NVS has received research and travel grants unrelated to this study from Gilead Sciences Greece, and GSK Greece. OK has received support unrelated to this study from Baxalta, Novonordisk, Bayer, Pfizer in the form of research grants, lecture fees, travel expenses, payment of registration fees. GV has received travel expenses unrelated to the submitted work from ECDC. PG has received grants unrelated to this study from Astellas, Gilead, Jansesen, MSD, ViiV. The rest of the authors have no funding relevant to this study to report. AMACS has received initial funding from the Hellenic Center of Disease Control and Prevention. Additional grants unrelated to this study were received by Gilead Sciences Europe. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures
References
-
- Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337(11):725–33. Epub 1997/09/11. 10.1056/NEJM199709113371101 . - DOI - PubMed
-
- Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71. Epub 2013/02/23. 10.1126/science.1228160 ; PubMed Central PMCID: PMC4255272. - DOI - PMC - PubMed
-
- UNAIDS. UNAIDS Data 2018. 2018.
-
- Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800. 10.1093/cid/ciq243 ; PubMed Central PMCID: PMCPMC3106261. - DOI - PMC - PubMed
-
- UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva: 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
